UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by OMNI 360 Wealth Inc.

OMNI 360 Wealth Inc. lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 676 shares of the healthcare conglomerate’s stock after buying an additional 76 shares during the quarter. OMNI 360 Wealth Inc.’s holdings in UnitedHealth Group were worth $395,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in UNH. Tealwood Asset Management Inc. purchased a new position in shares of UnitedHealth Group in the third quarter valued at approximately $2,905,000. Asset Planning Services Inc. LA ADV lifted its holdings in UnitedHealth Group by 1.2% in the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock valued at $7,288,000 after purchasing an additional 150 shares in the last quarter. Vantage Investment Partners LLC grew its holdings in shares of UnitedHealth Group by 42.2% during the first quarter. Vantage Investment Partners LLC now owns 152,107 shares of the healthcare conglomerate’s stock worth $75,247,000 after buying an additional 45,173 shares in the last quarter. Sequoia Financial Advisors LLC raised its position in shares of UnitedHealth Group by 13.7% in the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock valued at $14,603,000 after buying an additional 3,006 shares during the last quarter. Finally, Maryland State Retirement & Pension System grew its stake in UnitedHealth Group by 0.6% during the 1st quarter. Maryland State Retirement & Pension System now owns 72,689 shares of the healthcare conglomerate’s stock valued at $35,126,000 after acquiring an additional 469 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $564.56 on Monday. The business has a 50-day simple moving average of $583.52 and a 200-day simple moving average of $538.58. The company has a market cap of $521.33 billion, a PE ratio of 36.78, a P/E/G ratio of 1.66 and a beta of 0.58. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $608.63. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s revenue was up 9.2% on a year-over-year basis. During the same period last year, the business earned $6.56 EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.49%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the company. Truist Financial restated a “buy” rating and set a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Wells Fargo & Company upped their target price on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Argus boosted their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. UBS Group reduced their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Finally, Robert W. Baird raised their price target on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.